Joshua Boger, Ph.D.
Affiliations: | 1989-2009 | CEO | Vertex Pharmaceuticals, Boston, MA, United States |
2012- | Alkeus Pharmaceuticals |
Google:
"Joshua Boger"Mean distance: 7.3 | S | N | B | C | P |
Parents
Sign in to add mentorMax Tishler | research assistant | 1969-1973 | Wesleyan |
Jeremy R. Knowles | grad student | 1973-1979 | Harvard |
Jean-Marie Lehn | post-doc | 1974-1978 | Université de Strasbourg |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Boger J, Knowles JR. (1979) Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: a host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution Journal of the American Chemical Society. 101: 7631-7633 |
Boger J, Brenner DG, Knowles JR. (1979) Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: preparation and characterization of primary trisubstituted .alpha.-cyclodextrins Journal of the American Chemical Society. 101: 7630-7631 |
Boger J, Knowles JR. (1979) Symmetrical triamino-per-O-methyl-α-cyclodextrin: A host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution [13] Journal of the American Chemical Society. 101: 7631-7633 |
Boger J, Corcoran RJ, Lehn J. (1978) Cyclodextrin chemistry. Selective modification of all primary hydroxyl groups of ?- and ?-cyclodextrins Helvetica Chimica Acta. 61: 2190-2218 |
Boger J, Knowles JR. (1977) To stabilize a transition state. Ciba Foundation Symposium. 225-42 |